90 related articles for article (PubMed ID: 28246471)
1. MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expression.
Lu ZJ; Wu JJ; Jiang WL; Xiao JH; Tao KZ; Ma L; Zheng P; Wan R; Wang XP
World J Gastroenterol; 2017 Feb; 23(6):976-985. PubMed ID: 28246471
[TBL] [Abstract][Full Text] [Related]
2. HBeAg induces the expression of macrophage miR-155 to accelerate liver injury via promoting production of inflammatory cytokines.
Wang W; Bian H; Li F; Li X; Zhang D; Sun S; Song S; Zhu Q; Ren W; Qin C; Qi J
Cell Mol Life Sci; 2018 Jul; 75(14):2627-2641. PubMed ID: 29349567
[TBL] [Abstract][Full Text] [Related]
3. miR-30c affects the pathogenesis of ulcerative colitis by regulating target gene VIP.
Dong X; Zhan Y; Yang M; Li S; Zheng H; Gao Y
Sci Rep; 2024 Feb; 14(1):3472. PubMed ID: 38342939
[TBL] [Abstract][Full Text] [Related]
4. Suppression of mir-150-5p attenuates the anti-inflammatory effect of glucocorticoids in mice with ulcerative colitis.
Wang Y; Qin J; Dong L; He C; Zhang D; Wu X; Li T; Yue H; Mu L; Wang Q; Yang J
Mol Immunol; 2023 Nov; 163():28-38. PubMed ID: 37729776
[TBL] [Abstract][Full Text] [Related]
5. Apigenin Targets MicroRNA-155, Enhances SHIP-1 Expression, and Augments Anti-Tumor Responses in Pancreatic Cancer.
Husain K; Villalobos-Ayala K; Laverde V; Vazquez OA; Miller B; Kazim S; Blanck G; Hibbs ML; Krystal G; Elhussin I; Mori J; Yates C; Ghansah T
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892872
[TBL] [Abstract][Full Text] [Related]
6. Expression of Concern: miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5.
Biosci Rep; 2023 Jun; 43(6):. PubMed ID: 37272744
[No Abstract] [Full Text] [Related]
7. MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis.
Liu Y; Zhu F; Li H; Fan H; Wu H; Dong Y; Chu S; Tan C; Wang Q; He H; Gao F; Leng X; Zhou Q; Zhu X
Aging (Albany NY); 2020 Jul; 12(14):14966-14977. PubMed ID: 32713852
[TBL] [Abstract][Full Text] [Related]
8. Suppression of miR-21 and miR-155 of macrophage by cinnamaldehyde ameliorates ulcerative colitis.
Qu S; Shen Y; Wang M; Wang X; Yang Y
Int Immunopharmacol; 2019 Feb; 67():22-34. PubMed ID: 30530166
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs in Inflammatory Bowel Disease and Its Complications.
Krishnachaitanya SS; Liu M; Fujise K; Li Q
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955886
[TBL] [Abstract][Full Text] [Related]
10. The potential role of miRNA in regulating macrophage polarization.
Khayati S; Dehnavi S; Sadeghi M; Tavakol Afshari J; Esmaeili SA; Mohammadi M
Heliyon; 2023 Nov; 9(11):e21615. PubMed ID: 38027572
[TBL] [Abstract][Full Text] [Related]
11. Multi-omics analysis reveals the interaction of gut microbiome and host microRNAs in ulcerative colitis.
Ma L; Hou C; Yang H; Chen Q; Lyu W; Wang Z; Wang J; Xiao Y
Ann Med; 2023; 55(2):2261477. PubMed ID: 37774039
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-155-5p inhibition alleviates irritable bowel syndrome by increasing claudin-1 and ZO-1 expression.
Guo JG; Rao YF; Jiang J; Li X; Zhu SM
Ann Transl Med; 2023 Jan; 11(2):34. PubMed ID: 36819593
[TBL] [Abstract][Full Text] [Related]
13. miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases?
Aggeletopoulou I; Mouzaki A; Thomopoulos K; Triantos C
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768556
[TBL] [Abstract][Full Text] [Related]
14. Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review.
Xu WD; Feng SY; Huang AF
Inflamm Res; 2022 Dec; 71(12):1501-1517. PubMed ID: 36308539
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155 expression is associated with pulpitis progression by targeting SHIP1.
Li B; Guo L; He Y; Tu X; Zhong J; Guan H; Jiang Y; Jiang Q
Mol Biol Rep; 2022 Sep; 49(9):8575-8586. PubMed ID: 35834034
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA and Gut Microbiota: Tiny but Mighty-Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics.
Casado-Bedmar M; Viennois E
J Crohns Colitis; 2022 Jul; 16(6):992-1005. PubMed ID: 34918052
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer.
Grillo TG; Quaglio AEV; Beraldo RF; Lima TB; Baima JP; Di Stasi LC; Sassaki LY
World J Gastrointest Oncol; 2021 Sep; 13(9):995-1016. PubMed ID: 34616508
[TBL] [Abstract][Full Text] [Related]
19. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155.
Guo J; Liao M; Wang J
Cell Commun Signal; 2021 Sep; 19(1):90. PubMed ID: 34479599
[TBL] [Abstract][Full Text] [Related]
20. The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer.
Bocchetti M; Ferraro MG; Ricciardiello F; Ottaiano A; Luce A; Cossu AM; Scrima M; Leung WY; Abate M; Stiuso P; Caraglia M; Zappavigna S; Yau TO
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
